This study is in progress, not accepting new patients
A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amicus Therapeutics
- ID
- NCT04138277
- Phase
- Phase 3 Pompe Disease Research Study
- Study Type
- Interventional
- Participants
- Expecting 110 study participants
- Last Updated